Immediate Impact
50 standout
Citing Papers
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
CAR T Cells and T-Cell Therapies for Cancer
2024 Standout
Works of Tom Martin being referenced
Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma
2021
Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Tom Martin | 234 | 170 | 192 | 22 | 355 | |
| Francesca Grasso | 165 | 41 | 193 | 11 | 370 | |
| Daiki Karigane | 135 | 50 | 118 | 30 | 320 | |
| Nicolas Stocker | 68 | 64 | 123 | 26 | 342 | |
| Joe N. Frost | 174 | 45 | 81 | 18 | 405 | |
| Hannah Brown | 38 | 111 | 79 | 34 | 402 | |
| Eric L. Simmons | 79 | 39 | 71 | 21 | 337 | |
| Haodong Cai | 92 | 172 | 153 | 27 | 397 | |
| Ilana Harari | 62 | 50 | 160 | 11 | 379 | |
| M Deschaseaux | 89 | 91 | 49 | 15 | 386 | |
| Ann Van de Velde | 149 | 77 | 123 | 29 | 363 |
All Works
Loading papers...